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Abstract
Purpose/Objective: Reproducible patient positioning remains one of the major challenges in modern radiation therapy.
Recently, optical surface scanners have been introduced into clinical practice in addition to well-established positioning systems,
such as room laser and skin marks. The aim of this prospective study was to evaluate setup errors of the optical surface scanner
Catalyst HD (C-RAD AB) in different anatomic regions. Material/Methods: Between October 2016 and June 2017 a total of
1902 treatment sessions in 110 patients were evaluated. The workflow of this study included conventional setup procedures using
laser-based positioning with skin marks and an additional registration of the 3-dimensional (3D) deviations detected by the
Catalyst system. The deviations of the surface-based method were then compared to the corrections of cone beam computed
tomography alignment which was considered as gold standard. A practical Catalyst setup error was calculated between the
translational deviations of the surface scanner and the laser positioning. Two one-sided t tests for equivalence were used for
statistical analysis.Results:Data analysis revealed total deviations of 0.09 mm+ 2.03 mm for the lateral axis, 0.07 mm+ 3.21 mm
for the longitudinal axis, and 0.44 mm+ 3.08 mm vertical axis for the Catalyst system, compared to 0.06+ 3.54 mm lateral,
0.53 + 3.47 mm longitudinal, and 0.19 + 3.49 mm vertical for the laser positioning compared to cone beam computed
tomography. The lowest positional deviations were found in the cranial region, and larger deviations occurred in the thoracic and
abdominal sites. A statistical comparison using 2 one-sided t tests showed a general concordance of the 2 methods (P  0.036),
excluding the vertical direction of the abdominal region (P ¼ 0.198). Conclusion: The optical surface scanner Catalyst HD is a
reliable and feasible patient positioning system without any additional radiation exposure. From the head to the thoracic and
abdominal region, a decrease in accuracy was observed within a comparable range for Catalyst and laser-assisted positioning.
Keywords
surface scanner, patient positioning, radiotherapy, catalyst, laser positioning, CBCT
Abbreviations
CBCT, cone beam computed tomography; IGRT, image-guided radiation therapy; LED, light-emitting diode; MVCT, mega voltage
computed tomography
Received: March 12, 2018; Revised: June 20, 2018; Accepted: September 05, 2018.
1 Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany
2 Department of Radiation Oncology, Sacro Cuore Don Calabria Hospital, Negrar-Verona, Italy
3 University of Brescia, Brescia, Italy
4 Department of Therapeutic Radiology and Oncology, Innsbruck Medical University, Innsbruck, Austria
*Authors have contributed equally to this study.
Corresponding Author:
S Corradini, MD, Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377 Munich, Germany.
Email: stefanie.corradini@med.uni-muenchen.de
Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License
(http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission
provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Technology in Cancer Research &
Treatment
Volume 17: 1-9
ª The Author(s) 2018
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/1533033818806002
journals.sagepub.com/home/tct
Introduction
In modern radiation oncology, the term “image-guided radiation
therapy (IGRT)” refers to the use of various imaging methods to
correct possible setup errors in patient position. In fact, the
reproducibility of patient setup and organ motion management
remains one of the major challenges in the daily clinical activ-
ities of radiation therapy.1 Technological improvements of
recent years, including the introduction of cone beam computed
tomography (CBCT), have significantly improved precise dose
delivery to the tumor and minimized uncertainties. Image-
guided technology is not only used to better assess the position
of the target during the treatment; advanced IGRT techniques
enable clinicians to perform dose escalation to tumor volumes
near surrounding sensitive organs at risk, and this approach was
the cornerstone of stereotactic radiotherapy.2,3 In addition, the
implementation of daily IGRT can minimize setup margins for
treatment planning volumes, which can potentially reduce side
effects by maintaining high local tumor control rates.4-6
However, the correct initial positioning of the patient
remains a crucial issue for accurate IGRT protocols. In cases
of major deviations in the patient’s treatment position, even a
precise IGRT realignment cannot perfectly compensate for
substantial anatomical divergences. Excluding CBCT, a num-
ber of other IGRT techniques are currently available, such as
fiducial markers inside the target volume monitored by portal
imaging, ultrasound systems, or electromagnetic online verifi-
cation with microprobes in the patient’s body. More recently,
newly developed optical surface positioning systems have been
introduced into clinical practice.7,8 Optical systems have been
investigated over a long period of time, but it was only after the
development of powerful central processing units that these
tools could be further developed into accurate, high-
resolution sensors.8 Nowadays, surface-based systems enable
a continuous and touchless optical surface scanning of the
patients’ external surfaces and are a helpful tool for accurate
patient positioning in 6 degrees of freedom without any addi-
tional radiation exposure. Furthermore, many commercial sys-
tems offer other features, including visual user assistance in the
identification of positioning deviations, intrafractional motion
control, and automated respiratory gating, especially in the
context of deep inspiration breath hold.9
As an example, optical tracking systems like AlignRT
(Vision RT Ltd, London, United Kingdom) used as positioning
system could show to be more accurate than laser positioning in
patients with whole breast or chest wall irradiation.10,11
In this study, the Catalyst HD optical surface scanner pro-
duced by C-RAD (Uppsala, Sweden) was analyzed for patient
positioning and compared to the clinical gold standard consist-
ing of manual positioning using skin marks and CBCT.
Material and Methods
This study was designed as a prospective observational study
and data collection was performed between October 2016 and
June 2017. The study was approved by the local ethics
committee of the University Hospital, LMU Munich (No.
352-16 ex 09/2016) and registered at German Clinical Trials
Register (DRKS-ID: DRKS00011407). Written informed con-
sent was obtained from all patients.
Optical Scanner System Catalyst HD
The optical surface scanner Catalyst HD from C-RAD consists
of 3 ceiling-mounted scanner units and the associated c4D-
software. The scanners in the linac room are arranged at an
angle of around 120 to each other in order to enable a con-
tinuous detection of the surface even if the gantry is rotating
around the patient (Figure 1). During the scan, the device emits
visible light with a wavelength of 405 nm (blue) and reprojec-
tions are captured by integrated charge-coupled device cam-
eras. The comparison of the surface scan with an initially
acquired reference scan is based on the principles of photo-
grammetry through optical triangulation and is carried out via
a nonrigid iterative closest point algorithm in 6 degrees of
freedom (lateral, longitudinal, vertical, rotation, roll, and
pitch). The scan field size is 800 mm  1300 mm  700 mm
with a maximum frame rate of 200 Hz. The camera settings
include an editable integration time and gain factor as well as
specific presets (concerning tolerances and averaging times)
for different treatment sections.
In addition, the system also features integrated light-
emitting diode (LED) projectors for projecting positional
deviations onto the patient’s surface to assist in patient posi-
tioning. For different deviations, different colored light (green:
528 nm, red: 624 nm) is used to visualize the reference position
on the patient surface. An example is shown in Figure 2.
Workflow
During the first treatment session, the patientwas initially aligned
using a CBCT scan (X-ray volume imaging by Elekta AB, Stock-
holm, Sweden) as a gold standard. Subsequently, the isocenter
was marked using skin marks via the positioning lasers. In addi-
tion, a reference surface scan for repeatable patient setup during
the course of the following fractions was created using the Cata-
lyst scanner, which took less than an additional minute.
According to the study protocol, during the following treat-
ment sessions, the patients were first positioned via the room
laser and skin marks. Thereafter, a Catalyst surface scan was
carried out and the shift values in regard to the optimal treat-
ment position (Catalyst reference scan) were recorded. Finally,
a CBCT was acquired, in which deviations were regarded as
gold standard. The final alignment of the patient prior to dose
delivery was always carried out on the basis of the CBCT. Cone
beam computed tomography registration was done automati-
cally or in a standardized manner following specific IGRT
standard operating procedures to reduce interuser deviations.
Nevertheless, the deviations recorded for laser-based and
catalyst-based positioning were correlated with the CBCT of
the same treatment session, and interuser deviations would
therefore be of minor importance. The daily workflow is
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depicted in Figure 3. If new skin marks were needed during the
treatment course, a new Catalyst reference scan was created.
Statistics
The shift values determined by the Catalyst system and the
CBCT in regard to laser-based positioning were recorded in 3
spatial levels for each treatment fraction. Treatment fractions
where no CBCT was acquired were excluded from the analysis.
Furthermore, in order to compare the systems, the deviation of
the Catalyst measurements to the CBCT was determined using
the following formula:
½dCatalystðlat=long=vertÞ  dCBCTðlat=long=vertÞ
¼ EPractical Catalyst error compared to CBCTðlat=long=vertÞ:
The measurements were analyzed with regard to the distri-
bution of values, common tendencies, standard deviations,
Figure 1. The 3 Catalyst HD scanners in the treatment room. The scanners are arranged at an angle of 120 to each other in order to enable a
continuous detection of the surface even if the gantry is rotating around the patient.
Figure 2. Positional deviations projected onto the patients’ surface (screenshot of Catalyst software c4D [C-Rad AB). Local deviations outside
the tolerance limits compared to the reference scan are marked in red.
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ranges, and deviations overall and reported separately accord-
ing to treatment regions. In order to statistically compare the 2
methods, the equivalence was tested via 2 one-sided t tests.
This test was used to analyze whether the difference in the
deviations was within a certain range (head: 0.5 mm; thorax:
1.0 mm; abdomen: 1.5 mm; extremities: 2.0 mm). Hypothesis
testing was also performed separately for the different treat-
ment regions. The significance level was set as a ¼ 0.05.
Statistical testing was performed using SPSS (IBM Corp.
Released 2016. IBM SPSS Statistics for Windows, Version
24.0. Armonk, New York: IBM Corp.) and XLSTAT
(XLSTAT: Data Analysis and Statistical Solution for Microsoft
Excel. Addinsoft, Paris, France) for the 2 one-sided t tests.
Results
A total of 1902 treatment fractions of 110 patients (66 males,
44 females) were recorded between October 2016 and July
2017. The average patient age was 65 years (range: 31-93).
The most common tumor sites included 16 lung tumors, 15
prostate cancers, 14 intracranial tumors, 14 soft tissue sarco-
mas, and 14 head and neck tumors. For further analyses, the
fractions were subdivided into the 4 treatment regions: head,
thorax, abdomen, and extremities. In total, data from 689
fractions of the head region, 460 fractions of the thorax, 630
fractions of the abdomen, and 123 fractions of the extremities
were evaluated.
For all treatment regions evaluated together, the mean
deviation recorded by the Catalyst system was 0.09 + 2.03
mm in the lateral axis, 0.07+ 3.21 mm in the longitudinal, and
0.44 + 3.08 mm in the vertical direction. In contrast, the
deviation of the laser-based positioning in regard to the CBCT
was 0.06 + 3.54 mm lateral, 0.53 + 3.47 mm longitudinal,
and 0.19+ 3.49 mm vertical. As a result, the practical Catalyst
error according to the given formula above including all data
samples was in mean 0.15+ 4.21 mm in the lateral direction,
0.46+ 4.47 mm in the longitudinal, and 0.25+ 4.54 mm in
the vertical axis. The distribution of the divergences is
described in Figure 4. A detailed comparison between the 2
methods regarding each treatment region is shown in Table 1
and Figure 5. Overall, both methods showed similar results
within a comparable range and with appropriate clinical accu-
racy. From the head to the thoracic and the abdominal region,
an increase in the average deviation and decrease in the preci-
sion was observed for both, the Catalyst as well as the laser-
based positioning. We observed an increase in mean values and
standard deviations from the head (eg, dCatalyst long 0.17 +
2.11 mm/dLaser long 0.29 + 1.89 mm) toward the abdominal
region (dCatalyst long 1.99 + 5.25 mm/dLaser long 1.56 +
4.18 mm). Statistical equivalence testing confirmed this and
showed a concordance between the 2 methods within the pre-
defined test limits (P < 0.036; Table 2). One exception was the
vertical axis of the abdominal region (P ¼ 0.198), where the
absolute Catalyst deviations were slightly closer to the CBCT
correction value as compared to the laser-based positioning
(mean of 0.59 mm vs 0.68 mm).
Discussion
Different optical systems have been evaluated for patient posi-
tioning in phantom studies or in different clinical settings.12-22
Concerning the general strengths and weaknesses of optical
systems, in most of these experiences, similar conclusions were
reported. In addition to the lack of ionizing radiation, optical
systems reach their maximum potential in terms of reliability,
especially in regions with a fixed tumor to surface correlation.
Although the Catalyst system is currently used for patient
positioning in several radiation oncology departments, there is
limited evidence of its actual reliability and accuracy in daily
clinical practice. In a recent retrospective study, Stanley et al
evaluated approximately 6000 fractions.23 The patients were
initially positioned either via skin marks and spatial lasers or
via the Catalyst system. The authors reported an average vector
deviation of 5 to 6 mm for Catalyst and 9 to 14 mm for room
lasers, depending on the anatomic district. The authors con-
cluded that Catalyst was a reliable alternative to conventional
Figure 3. Daily workflow.
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positioning via skin marks and room lasers and was able to
further optimize initial patient positioning. One drawback is
the retrospective design of this study. In contrast to the present
prospective study, patient alignment was performed either by
the optical system or by the laser-based system and compared
retrospectively to CBCT scans. One of the strengths of the
Figure 4. Histograms showing distributions of Catalyst and laser deviations along all 3 spatial directions.
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present analysis is that we followed a standardized workflow
and compared the optical scan of the same treatment session to
the laser-based positioning in order to avoid intrafractional
uncertainties.
Recently, the positioning accuracy using absolute median
values of Catalyst and laser positioning for patients with rectal
cancer has been compared: A significant difference was only
observed in the lateral direction for the benefit of the Catalyst
system with a median positioning accuracy of 1.3 cm versus
2.0 cm for the laser, and longitudinal and vertical direction did
not show any performance differences between the 2 methods.24
An early study of our department retrospectively compared
the Catalyst system to spatial laser positioning.25 A total of 154
treatment fractions of about 25 patients treated in the region of
the thorax, abdomen, and pelvis were retrospectively evalu-
ated. Positioning using skin marks resulted in deviations of
0.0 + 2.1 mm laterally, 0.4 + 2.4 mm longitudinally, and
1.1+ 2.6 mm vertically. The error calculated for the Catalyst
was 0.1+ 2.1 mm lateral, 1.8+ 5.4 mm longitudinal, and
1.4 + 3.2 mm vertical. A statistical analysis showed only one
significant difference between the 2 methods in the longitudi-
nal axis of the pelvic area. In our setting, we were able to
reproduce the good precision of the laser-based positioning and
obtained deviations of similar proportions for both systems.
Despite the very similar design of the study, the standardized
workflow, the larger cohort of patients, and the greater number
of analyzed fractions could result in better results.
Table 1. Catalyst and Spatial Laser Deviations Sorted by Region.
All Values in mm
Mean
Value 95% CI SD Range
Catalyst deviations sorted by therapeutic regions
Head
Catalyst lat. 0.21 [0.37; 0.05] +2.14 15.4; 11.8
Laser lat. 0.18 [0.31; 0.06] +1.71 5.3; 5.1
Catalyst long. 0.17 [0.02; 0.33] +2.11 9.7; 9.1
Laser long. 0.29 [0.14; 0.43] +1.89 29.6; 8.0
Catalyst vert. 0.13 [0.08; 0.35] +2.88 11.0; 15.3
Laser vert. 0.03 [0.20; 0.14] +2.27 10.1; 8.6
Thorax
Catalyst lat. 0.13 [0.55; 0.30] +4.67 18.1; 15.3
Laser lat. 0.21 [0.58; 0.16] +4.06 18.7; 15.1
Catalyst long. 1.14 [1.57; 0.71] +4.66 15.6; 16.8
Laser long. 0.65 [0.98; 0.31] +3.65 11.2; 12.6
Catalyst vert. 0.01 [0.44; 0.41] +4.64 18.9; 14.0
Laser vert. 0.22 [0.16; 0.61] +4.18 19.7; 14.1
Abdomen
Catalyst lat. 0.46 [0.84; 0.08] +4.85 16.6; 12.9
Laser lat. 0.06 [0.37; 0.26] +4.03 13.8; 11.2
Catalyst long. 1.99 [1.58; 2.40] +5.25 15.2; 23.0
Laser long. 1.56 [1.23; 1.89] +4.18 29.1; 22.5
Catalyst vert. 0.59 [1.03; 0.16] +5.58 18.8; 19.8
Laser vert. 0.68 [0.37; 0.98] +3.93 10.5; 13.8
Extremities
Catalyst lat. 1.71 [0.55; 2.87] +6.50 17.1; 16.5
Laser lat. 1.18 [0.18; 2.19] +5.63 12.5; 14.4
Catalyst long. 0.18 [0.96; 1.32] +6.38 17.4; 16.9
Laser long. 0.96 [0.26; 1.66] +3.90 10.4; 11.2
Catalyst vert. 1.57 [2.52; 0.62] +5.34 16.6; 10.9
Laser vert. 1.20 [1.80; 0.59] +3.38 14.0; 6.0
Abbreviations: CI, confidence interval; SD, standard deviation; lat., lateral;
long., longitudinal; vert., vertical.
Figure 5. Catalyst and laser deviations sorted by region along the
3 directions.
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In a recent clinical report by Crop et al, the Catalyst system
was compared to positioning by spatial laser and a mega
voltage computed tomography (MVCT) using TomoTherapy
(Accuray, Sunnyvale, California).26 The study included
mainly patients with breast cancer. Interuser dependent
MVCT deviations as well as intrafractional patient move-
ments were measured in order to include the human factor
as well as the timing component in the system’s evaluation.
The authors concluded that Catalyst was superior to the spa-
tial laser in terms of positioning capabilities and was not
significantly inferior to the MVCT. Specifically, the shorter
time interval between scan and repositioning was described as
a major advantage of the optical system, since the largest
increase in random patient movements was recorded within
the first 5 minutes after positioning. Similarly, the interuser
dependent variation in manual MVCT matching was seen as
an important factor influencing accuracy.
More recently, Ma et al used an Optical Surface Manage-
ment System in breast cancer radiotherapy for interfractional
patient positioning measurements compared to CBCT. As a
conclusion, the 2 systems did not show any difference for all
3 possible spatial axes.27
Stieler et al evaluated a direct comparison between the Cat-
alyst system and patient positioning using CBCT.28 In the clin-
ical part of the study, 224 fractions of 13 patients with
treatments of the head/neck, thorax, and abdomen were eval-
uated. The authors reported deviations of the Catalyst system of
0.7+ 2.8 mm lateral, 1.3+ 4.0 mm longitudinal, and 1.5+
3.6 mm vertical across all regions. Overall, a good correlation
between the results of the 2 methods, especially in the case of
tumor entities with a fixed tumor-to-surface relationship, was
described. However, it also emphasizes the dependence of the
results on the correct camera settings for good image quality.
With regard to this study, patient positioning using Catalyst
was reliable in all clinical situations. Compared to laser posi-
tioning which is a more or less focusing on several target
points, an advantage of this surface scanner is the observation
of a larger body surface area in form of a 3D image (Figure 2).
Together with optical LED reprojection, it can highlight body
areas that exceed position tolerance limits compared to a ref-
erence image in real time which facilitates patient positioning
in everyday clinical workflow. Additionally, no skin marks are
necessary for using surface scanning, which is more patient-
friendly and saves time for skin marks drawing/redrawing for
the clinical staff. Although surface scanning is unlikely to
replace X-ray imaging if the target volume is not close to the
surface, the data presented here indicate sufficient accuracy for
daily use. In our setup, patient positioning using Catalyst
achieved at least the same precision as positioning using spatial
laser. The relatively high precision of laser-based positioning
through well-trained staff has already been highlighted in a
previous study of our institution.25 The highest precision of the
optical system was achieved in scans of the head area, which is
presumably due to the relatively narrow tumour to surface
correlation and obviously due to the rigid fixation with immo-
bilizing masks. The positioning accuracy in the thoracic and
abdominal areas decreased compared to the head area but
remained comparable to laser-based positioning with average
deviations within the range of a few millimetres. As already
assumed by other authors, breathing movements and the result-
ing motion of internal organs, as well as the symmetric body
shape along the longitudinal axis, might be responsible for the
deviations of the optical system in comparison to CBCT.29
Likewise, the variable position of internal organs due to differ-
ent levels of bladder/bowel fillings can influence external sur-
face positioning and can thus be regarded as an influencing
factor for the precision of the optical systems.17,30,31
Conclusion
In conclusion, the optical surface system Catalyst HD is a
reliable and feasible patient positioning system without any
additional radiation exposure. From the head to the thoracic
and abdominal region, an increase in the average deviation and
a decrease in precision were observed within a comparable
range for Catalyst and laser-assisted positioning based on the
used gold standard (CBCT).
Authors’ Note
G.C. and D.R. contributed equally to this study. G.C. performed data
extraction, the statistical analysis, and drafted the manuscript. D.R.
supervised and helped with statistical analysis and to write the manu-
script. S.S., M.P., M.N., U.G. reviewed the manuscript. S.C. and A.F.
helped to finalize the manuscript. P.F. and M.R. planned and orga-
nized the technical settings. C.B. and S.C. designed and supervised the
study. All authors read and approved the final manuscript. The study
was approved by the local ethics committee of the University Hospital,
LMU Munich (No. 352-16 ex 09/2016) and registered at German
Table 2. Two One-Sided t Tests for Equivalence Results (P Value)
Sorted by Region and Spatial Axes.
All Values in mm Test Boundaries
90% CI of the
Differences of
Mean Value P
TOST (2 one-sided t tests)
Head
Lateral 0.5; 0.5 [0.140; 0.203] <.001
Longitudinal 0.5; 0.5 [0.065; 0.290] .000
Vertical 0.5; 0.5 [0.396; 0.064] .008
Thorax
Lateral 1.0; 1.0 [0.560; 0.391] .001
Longitudinal 1.0; 1.0 [0.036; 0.946] .033
Vertical 1.0; 1.0 [0.246; 0.713] .004
Abdomen
Lateral 1.5; 1.5 [0.009; 0.819] <.001
Longitudinal 1.5; 1.5 [0.866; 0.014] <.001
Vertical 1.5; 1.5 [0.821; 1.716] .198
Extremities
Lateral 2.0; 2.0 [1.809; 0.752] .029
Longitudinal 2.0; 2.0 [0.333; 1.893] .036
Vertical 2.0; 2.0 [0.567; 1.315] .002
Abbreviation: CI, confidence interval.
Carl et al 7
Clinical Trials Register (DRKS-ID: DRKS00011407). Written
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